Publications
- Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial +12012 | First Faculty of Medicine
- Treatment of multiple myeloma with lenalidomide in 20122012 | First Faculty of Medicine
- Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial2010 | First Faculty of Medicine
- Autologous stem cell transplantation for AL amyloidosis –single-center results of a strict risk-adapted approach.2010 | First Faculty of Medicine
- Retrospective Analysis of the Results of High-dose Chemotherapy with the Support of Autologous Blood Stem Cells in Patients with Multiple Myeloma. The Experience of a Single Centre2010 | First Faculty of Medicine
- Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma2009 | First Faculty of Medicine
- Bortezomid in the first line therapy2009 | First Faculty of Medicine
- Lenalidomid (Revlimid) in the Treatment of Multiple Myeloma – First Experience in the Czech Republic2008 | First Faculty of Medicine
- Molecular cytogenetic study of immunofluorescently labeled plasma cells in patients with multiple myeloma enrolled in study CMG 20022008 | First Faculty of Medicine
- Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma2008 | First Faculty of Medicine
Loading network view...
